Search

Aurora M. Fontainhas

Examiner (ID: 13101, Phone: (571)272-2952 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1675, 1649
Total Applications
685
Issued Applications
280
Pending Applications
96
Abandoned Applications
322

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5360501 [patent_doc_number] => 20090035295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies' [patent_app_type] => utility [patent_app_number] => 11/885362 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 41445 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035295.pdf [firstpage_image] =>[orig_patent_app_number] => 11885362 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885362
Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies Mar 2, 2006 Abandoned
Array ( [id] => 5630995 [patent_doc_number] => 20060147463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'HSP20 inhibits amyloidogenesis and neurotoxicity' [patent_app_type] => utility [patent_app_number] => 11/139770 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14678 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147463.pdf [firstpage_image] =>[orig_patent_app_number] => 11139770 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/139770
HSP20 inhibits amyloidogenesis and neurotoxicity May 25, 2005 Issued
Array ( [id] => 5141336 [patent_doc_number] => 20070003552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation' [patent_app_type] => utility [patent_app_number] => 11/087102 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38646 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003552.pdf [firstpage_image] =>[orig_patent_app_number] => 11087102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/087102
Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation Mar 20, 2005 Abandoned
Array ( [id] => 5902428 [patent_doc_number] => 20060045853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity' [patent_app_type] => utility [patent_app_number] => 11/033105 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26626 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045853.pdf [firstpage_image] =>[orig_patent_app_number] => 11033105 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/033105
Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity Jan 9, 2005 Abandoned
Array ( [id] => 12543120 [patent_doc_number] => 10010574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Silk peptide for improving neuroprotective and neurofunctional effects and a method of its preparation [patent_app_type] => utility [patent_app_number] => 11/572944 [patent_app_country] => US [patent_app_date] => 2004-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 12357 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11572944 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572944
Silk peptide for improving neuroprotective and neurofunctional effects and a method of its preparation Jul 30, 2004 Issued
Array ( [id] => 7098429 [patent_doc_number] => 20050130888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Metallothionein based neuronal therapeutic and therapeutic methods' [patent_app_type] => utility [patent_app_number] => 10/517653 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7644 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130888.pdf [firstpage_image] =>[orig_patent_app_number] => 10517653 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/517653
Metallothionein based neuronal therapeutic and therapeutic methods Jun 12, 2003 Issued
Array ( [id] => 6628251 [patent_doc_number] => 20030211085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Cell therapy for chronic stroke' [patent_app_type] => new [patent_app_number] => 10/009036 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6852 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211085.pdf [firstpage_image] =>[orig_patent_app_number] => 10009036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/009036
Cell therapy for chronic stroke Sep 29, 2002 Abandoned
Menu